Jeune Aesthetics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference

Rhea-AI Summary

PITTSBURGH, Dec. 5, 2022 – Jeune Aesthetics, a subsidiary of Krystal Biotech (NASDAQ: KRYS), announced its participation in the Cantor Fitzgerald Medical and Aesthetic Dermatology Conference on December 8 in Miami. Senior VP September Riharb will join a panel titled Distraction or Destruction: What’s New/Next in the Industry at 11:00 am ET. The management team will also engage in investor meetings that day. Jeune focuses on reversing aging skin through a gene-delivery platform.

PITTSBURGH, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) today announced that the company will participate in the investor-focused Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference, which is taking place in Miami on December 8.

September Riharb, Senior Vice President of Marketing for Jeune, will participate in an aesthetic dermatology panel on December 8 at 11:00 am ET, Distraction or Destruction: What’s New/Next in the Industry. The Jeune and Krystal management team will also attend investor meetings on December 8.

About Jeune Aesthetics, Inc.

Jeune Aesthetics, Inc., a wholly-owned subsidiary of Krystal Biotech, Inc., is a biotechnology company leveraging a clinically validated gene-delivery platform to fundamentally address – and reverse – the biology of aging skin. For more information, please visit http://www.jeuneinc.com.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The Company’s wide-ranging pipeline is based on its proprietary redosable HSV vector. Headquartered in Pittsburgh, Pennsylvania, the Company is led by an experienced management team, is fully-integrated and has core capabilities in viral vector design, vector optimization, gene therapy manufacturing and commercialization. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACT:

Investors and Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com

Source: Krystal Biotech, Inc.

 

 

FAQ

What event is Krystal Biotech's Jeune Aesthetics attending on December 8, 2022?

Jeune Aesthetics, a subsidiary of Krystal Biotech, will attend the Cantor Fitzgerald Medical and Aesthetic Dermatology Conference in Miami on December 8, 2022.

Who will represent Jeune Aesthetics at the Cantor Fitzgerald Conference?

September Riharb, Senior VP of Marketing for Jeune Aesthetics, will represent the company at the conference.

What is the focus of the panel discussion Jeune Aesthetics is participating in?

The panel discussion is titled Distraction or Destruction: What’s New/Next in the Industry and is scheduled for December 8 at 11:00 am ET.

What does Jeune Aesthetics specialize in?

Jeune Aesthetics specializes in biotechnology aimed at reversing the biology of aging skin through a clinically validated gene-delivery platform.

What is the stock symbol for Krystal Biotech?

The stock symbol for Krystal Biotech is KRYS, and it is listed on NASDAQ.